LJPC : Summary for La Jolla Pharmaceutical Company - Yahoo Finance

U.S. Markets close in 2 hrs 2 mins

La Jolla Pharmaceutical Company (LJPC)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
18.19+0.41 (+2.31%)
As of 1:47 PM EST. Market open.
People also watch:
INSMTGENNBIXLGNDIMMU
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close17.78
Open18.03
Bid18.20 x 100
Ask18.28 x 200
Day's Range17.80 - 18.71
52 Week Range12.68 - 32.15
Volume22,634
Avg. Volume148,188
Market Cap332.04M
Beta0.77
PE Ratio (TTM)-4.81
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • La Jolla Pharmaceutical Co. breached its 50 day moving average in a Bullish Manner : LJPC-US : November 14, 2016
    Capital Cube21 days ago

    La Jolla Pharmaceutical Co. breached its 50 day moving average in a Bullish Manner : LJPC-US : November 14, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for La Jolla Pharmaceutical Co.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day ... Read more (Read more...)

  • Capital Cube27 days ago

    ETF’s with exposure to La Jolla Pharmaceutical Co. : November 8, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to La Jolla Pharmaceutical Co. Here are 5 ETF’s with the largest exposure to LJPC-US. Comparing the performance and risk of La Jolla Pharmaceutical Co. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • La Jolla Pharmaceutical Co. :LJPC-US: Earnings Analysis: Q3, 2016 By the Numbers : November 7, 2016
    Capital Cube28 days ago

    La Jolla Pharmaceutical Co. :LJPC-US: Earnings Analysis: Q3, 2016 By the Numbers : November 7, 2016

    Categories: Yahoo Finance Get free summary analysis La Jolla Pharmaceutical Co. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of La Jolla Pharmaceutical Co. – Repligen Corporation, Vical Incorporated and Amgen Inc. (RGEN-US, VICL-US and AMGN-US) that have also reported for this period. Highlights Summary numbers: Revenues ... Read more (Read more...)